ICO
Closing Date:
Seeking Novel Drug Candidates and Targets for Progressive Fibrosing Interstitial Lung Diseases and Acute Respiratory Distress Syndrome
CSL is interested in respiratory therapeutics in the areas of Interstitial Lung Diseases (ILD) and Acute Respiratory Distress Syndrome (ARDS).
For ILD‑related research, halting and reversing fibrosis is a key element of interest. For ARDS‑related research, a focus on Community Acquired Pneumonia (CAP) is of key importance.
Approaches of Particular Interest
- Biologics and Antibody Therapeutics will be prioritized
- Cell and Gene Therapies
Developmental Stage
Validation with patient data, biomarkers, and/or in animal models preferable. Ex vivo models (e.g....
To see the full details and submit your response please register now
Benefits of registration:
- Receive updates on the latest industry calls
- Quickly and easily respond to calls via your dashboard
- Build your academic profile